C. Meier et al., cycloSal-pronucleotides of 2 '-fluoro-ara- and 2 '-fluoro-ribo-2 ',3 '-dideoxyadenosine as a strategy to bypass a metabolic blockade, J MED CHEM, 42(9), 1999, pp. 1615-1624
Novel, lipophilic cycloSal triesters 4a-c and 5a-c were synthesized, respec
tively, from the ara- and ribo-configurated 2'-fluorinated-2',3'-dideoxyade
nosines 2 and 3. The cycloSal phosphotriesters were used as tools to study
the effects of the two different sugar pucker conformations induced by two
opposite configurations of the fluorine substituent at C2' of the dideoxyri
bose moiety. F-ara-ddA (2) is known to be an active anti-HIV agent, whereas
the ribo-analogue 3 is inactive. Hydrolysis studies with the triester prec
ursors 4a-c and 5a-c showed selective formation of the monophosphates of 2
and 3. The lipophilicity of the triester prodrugs was considerably increase
d by the cycloSal mask with respect to ddA (1), F-ara-ddA (2), and F-ribo-d
dA (3). Phosphotriesters 4 and 5 proved to be completely resistant to ADA a
nd AMPDA deamination. In parallel experiments, ribo-nucleoside 3 showed a 5
0-fold faster deamination rate relative to the ara-analogue 2. Against HIV
in CEM cells, the phosphotriesters 4 proved to be 10-fold more potent than
the parent nucleoside 2. Furthermore, the prodrugs 4 were active against MS
V-induced transformation of C3H/3T3 fibroblasts, while 2 was inactive. More
interestingly, the ribo-configurated phosphotriesters 5, prepared from the
inactive F-ribo-ddA (3), showed a level of anti-HIV activity that was even
higher than that of F-ara-ddA (2). Our findings clearly prove that the app
lication of the cycloSal-pronucleotide concept to F-ribo-ddA (3) overcomes
a metabolic blockade in the formation of the corresponding monophosphate.